BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 7956212)

  • 1. Blood pressure changes and hormonal contraceptives.
    Shen Q; Lin D; Jiang X; Li H; Zhang Z
    Contraception; 1994 Aug; 50(2):131-41. PubMed ID: 7956212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    Wilson ES; Cruickshank J; McMaster M; Weir RJ
    Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
    Nichols M; Robinson G; Bounds W; Newman B; Guillebaud J
    Contraception; 1993 Apr; 47(4):367-76. PubMed ID: 8508666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G; Kohlmeier L; Brenner H
    Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose oral contraception and blood pressure in women with a past history of elevated blood pressure.
    Tsai CC; Williamson HO; Kirkland BH; Braun JO; Lam CF
    Am J Obstet Gynecol; 1985 Jan; 151(1):28-32. PubMed ID: 3966503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal contraception.
    Baird DT; Glasier AF
    N Engl J Med; 1993 May; 328(21):1543-9. PubMed ID: 8479492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the oral contraceptive pill on protein S and antithrombin-III levels in Malaysian women.
    Wong KK; Ng SC; Koong PL
    Med Sci Res; 1992 Jun 16-30; 20(12):439-40. PubMed ID: 12288974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the contraceptive pill on blood pressure: a randomized controlled trial of three progestogen-oestrogen combinations in Szeged, Hungary.
    Kovacs L; Bartfai G; Apró G; Annus J; Bulpitt C; Belsey E; Pinol A
    Contraception; 1986 Jan; 33(1):69-77. PubMed ID: 3082592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure in women using oral contraceptives: results from the Health Survey for England 1994.
    Dong W; Colhoun HM; Poulter NR
    J Hypertens; 1997 Oct; 15(10):1063-8. PubMed ID: 9350579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid and biochemical changes after low-dose oral contraception.
    Loke DF; Ng CS; Holck S; Hall PE; Ratnam SS
    Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.